Umlobi: William Ramirez
Usuku Lokudalwa: 18 Usepthemba 2021
Ukuvuselela Usuku: 1 Ujulayi 2024
Anonim
RESVERATROL & PTEROSTILBENE | Why I Stopped Taking Them
Ividiyo: RESVERATROL & PTEROSTILBENE | Why I Stopped Taking Them

-Delile

I-Resveratrol yikhemikhali etholakala ewayinini elibomvu, izikhumba zamagilebhisi abomvu, ijusi lamagilebhisi ansomi, ama-mulberries, nangamanani amancane kumantongomane. Isetshenziswa njengomuthi.

I-Resveratrol ijwayele ukusetshenziselwa i-cholesterol ephezulu, umdlavuza, isifo senhliziyo, nezinye izimo eziningi. Kodwa-ke, abukho ubufakazi obuqinile bokuxhasa ukusetshenziswa kwe-resveratrol yalokhu kusetshenziswa.

Imibhalo Yemvelo Yemininingwane Ephelele ukukala ukusebenza ngokuncike ebufakazini besayensi ngokwesilinganiso esilandelayo: Okusebenzayo, Okungenzeka Kusebenze, Okungenzeka Kusebenze, Okungenzeka Kungasebenzi, Cishe Okungaphumeleli, Ukungasebenzi, Nobufakazi Obunganele Bokulinganisa.

Izilinganiso zokusebenza ze I-RESVERATROL zimi kanje:

Kungenzeka kusebenze ...

  • Imfiva ethimulisayo. Ukusebenzisa isifutho samakhala esiqukethe i-resveratrol kathathu nsuku zonke amasonto ama-4 kubonakala kunciphisa izimpawu zokungezwani komzimba nabantu abadala abanezifo ezithile zonyaka. Ukusebenzisa isifutho samakhala esiqukethe i-resveratrol ne-beta-glucans kathathu nsuku zonke izinyanga ezi-2 nakho kubonakala sengathi kunciphisa izimpawu zokungezwani komzimba nezingane ezinokungezwani nezikhathi ezithile zonyaka.
  • Ukukhuluphala ngokweqile. Olunye ucwaningo lubonisa ukuthi ukuthatha i-resveratrol kungakhuphula ukulahleka kwesisindo kubantu abadala abakhuluphele.

Kungenzeka kungasebenzi ku ...

  • Isifo senhliziyo. Abantu abadla inani eliphakeme le-resveratrol yokudla akubonakali benengozi encane yesifo senhliziyo uma kuqhathaniswa nabantu abadla amanani aphansi. Futhi, ukuthatha i-resveratrol ngomlomo akubonakali kuthuthukisa amazinga e-cholesterol noma amafutha egazi abizwa nge-triglycerides kubantu abasengozini yesifo senhliziyo.
  • Ukuqoqwa kwezimpawu ezandisa ubungozi besifo sikashukela, isifo senhliziyo, nesifo sohlangothi (isifo se-metabolic syndrome). Ukuthatha i-resveratrol akubonakali kwehlisa umfutho wegazi, ushukela wegazi, noma i-cholesterol kubantu abane-metabolic syndrome. Ucwaningo lokuqala lukhombisa ukuthi i-resveratrol ingasiza ekwehliseni isisindo somzimba namafutha omzimba kubantu abane-metabolic syndrome. Kepha kudingeka olunye ucwaningo ukuqinisekisa.
  • Yakha amafutha esibindini kubantu abaphuza utshwala obuncane noma abangaphuzi (isifo sesibindi esinamafutha noma i-NAFLD). Ucwaningo oluningi lwakuqala lukhombisa ukuthi i-resveratrol ayithuthukisi ukusebenza kwesibindi, ukusikeka kwesibindi, noma amazinga we-cholesterol kubantu abane-NAFLD.

Ubufakazi obanele bokukala ukusebenza kwe ...

  • Izinduna. Ucwaningo lwakuqala lukhombisa ukuthi ukufaka ijeli equkethe i-resveratrol ebusweni izinsuku ezingama-60 kunciphisa ubunzima benduna.
  • Nciphisa amakhono wokukhumbula nokucabanga okwenzeka ngokujwayelekile ngobudala. Akucaci ukuthi ngabe i-resveratrol iyasiza yini ngememori noma amakhono okucabanga kubantu asebekhulile. Olunye ucwaningo lwakuqala lukhombisa ukuthi i-resveratrol ingahle ithuthukise amakhono okucabanga nenkumbulo kwabesifazane ngemuva kokuya esikhathini. Kodwa olunye ucwaningo lubonisa ukuthi i-resveratrol enikezwe ngemithamo ephezulu noma isikhathi eside ayithuthukisi inkumbulo noma amakhono okucabanga kubantu abadala asebekhulile.
  • Isifo segazi esinciphisa amazinga wamaprotheni egazini okuthiwa i-hemoglobin (beta-thalassemia). Ucwaningo lokuqala lubonisa ukuthi ukuthatha i-trans-resveratrol akukuthuthukisi amazinga e-hemoglobin noma isidingo sokumpontshelwa igazi kubantu abane-beta-thalassemia.
  • Umdlavuza. Abantu abadla inani eliphakeme le-resveratrol yokudla akubonakali benengozi encane yomdlavuza uma kuqhathaniswa nabantu abadla amanani aphansi.
  • Isifo sikashukela. Olunye ucwaningo lukhombisa ukuthi i-resveratrol ithuthukisa ukulawula ushukela egazini kubantu abanesifo sikashukela. Kepha olunye ucwaningo alukhombisi nzuzo. I-Resveratrol ingasiza ukwehlisa ushukela wegazi ezigulini kuphela ezinamazinga kashukela egazi angalawulwa kahle. Kudingeka olunye ucwaningo ukuqinisekisa.
  • Ukulimala kwezinso kubantu abanesifo sikashukela (isifo sikashukela nephropathy). Ucwaningo lwakuqala lukhombisa ukuthi ukuthatha i-resveratrol ne-losartan yezidakamizwa kungathuthukisa ezinye izinyathelo zokulimala kwezinso kubantu abane-nephropathy yesifo sikashukela.
  • Isifo samaphaphu esenza kube nzima ukuphefumula (isifo esingapheliyo sokuphazamiseka kwamaphaphu noma i-COPD). Ucwaningo lokuqala lubonisa ukuthi ukuthatha umkhiqizo ohlanganisiwe oqukethe i-resveratrol, i-vitamin C, i-zinc, ne-flavonoids kunciphisa kancane ukukhwehlela nokukhiqizwa kwamafinyila kubantu abane-COPD. Kodwa akucaci ukuthi inzuzo ibangelwa i-resveratrol noma ezinye izithako.
  • I-osteoarthritis. Ucwaningo lokuqala lukhombisa ukuthi ukufaka i-resveratrol ekwelashweni okujwayelekile kwamadolo i-osteoarthritis kungathuthukisa ubuhlungu, ukusebenza, nokuqina ngaphezu kwezindlela ezijwayelekile zokwelapha kuphela.
  • Ukwenza ngcono inqubo yezokwelapha ebizwa nge-peritoneal dialysis. Ucwaningo lokuqala lukhombisa ukuthi i-resveratrol ingenza ukuhlunga igazi kuhambe ngokushesha kubantu abathola i-peritoneal dialysis.
  • Isifo se-hormonal esibangela ama-ovari akhulisiwe ngama-cysts (i-polycystic ovary syndrome noma i-PCOS). Ucwaningo lokuqala lukhombisa ukuthi i-resveratrol inciphisa i-testosterone kwabesifazane abane-PCOS. Kodwa ayithuthukisi isisindo, amazinga e-lipid, induna, noma ukukhula kwezinwele okungafuneki kubantu besifazane abanalesi simo.
  • Isifo samathambo (RA). Ukuthatha i-resveratrol kanye nezidakamizwa ze-RA kubonakala kunciphisa inani lamalunga abuhlungu futhi avuvukile. Kodwa akwaziwa ukuthi i-resveratrol nayo iyasiza ukunciphisa ukulimala okuhlangene.
  • Uhlobo lwesifo samathumbu esivuthayo (ulcerative colitis). Ucwaningo lokuqala lubonisa ukuthi i-resveratrol ingahle ithuthukise izimpawu futhi yehlise umsebenzi we-ulcerative colitis.
  • Isikhumba esiguga.
  • Nciphisa amakhono okukhumbula nawokucabanga kubantu asebekhulile okungaphezu kokujwayelekile ngeminyaka yabo.
  • Ukuqina kwemithambo yegazi (i-atherosclerosis).
  • Amakhono wokukhumbula nokucabanga (umsebenzi wokuqonda).
  • Ezinye izimo.
Kudingeka ubufakazi obuningi ukukala i-resveratrol yalokhu kusetshenziswa.

I-Resveratrol ingakhulisa imithambo yegazi futhi inciphise umsebenzi wamaseli abalulekile ekunqandeni igazi. Olunye ucwaningo lubonisa ukuthi i-resveratrol inemiphumela ebuthakathaka ye-estrogen (i-hormone yabesifazane). Kunganciphisa nobuhlungu nokuvuvukala (ukuvuvukala). I-Resveratrol inganciphisa amazinga kashukela (i-glucose) egazini futhi isize umzimba ulwe nezifo. Kungavimbela futhi amaprotheni ebuchosheni ekuhlanganeni ndawonye ukusiza ukuvikela izifo ezifana nesifo i-Alzheimer's.

Lapho ithathwa ngomlomo: Resveratrol kuyinto CISHE UVIKILE lapho isetshenziswa kumanani atholakala ekudleni. Lapho ithathwa ngemithamo efinyelela ku-1500 mg nsuku zonke kuze kufike ezinyangeni ezintathu, i-resveratrol iyi OKUNGENZEKA UKUPHEPHA. Imithamo ephakeme efinyelela ku-2000-3000 mg nsuku zonke isetshenziswe ngokuphepha izinyanga ze-2-6. Kodwa-ke, le mithamo ephakeme ye-resveratrol kungenzeka ukuthi idale izinkinga zesisu.

Lapho isetshenziswa esikhunjeni: Resveratrol kuyinto OKUNGENZEKA UKUPHEPHA lapho isetshenziswa esikhumbeni kuze kube yizinsuku ezingama-30.

Ukuqapha okukhethekile nezixwayiso:

Ukukhulelwa nokuncelisa ibele: Resveratrol kuyinto CISHE UVIKILE lapho isetshenziswa ngamanani atholakala kokunye ukudla. Kodwa-ke, ngesikhathi sokukhulelwa nokuncelisa, umthombo we-resveratrol ubalulekile. I-Resveratrol itholakala kwizikhumba zamagilebhisi, ijusi lamagilebhisi, iwayini, neminye imithombo yokudla. Iwayini akufanele lisetshenziswe njengomthombo we-resveratrol ngesikhathi sokukhulelwa nalapho uncelisa.

Izingane: Resveratrol kuyinto OKUNGENZEKA UKUPHEPHA ezinganeni lapho zifuthwa emakhaleni kuze kufike ezinyangeni ezimbili.

Izinkinga zokopha: I-Resveratrol inganciphisa ukujiya kwegazi futhi inyuse ingozi yokuphuma kwegazi kubantu abanezinkinga zokopha.

Isimo esizwela i-Hormone njengomdlavuza webele, umdlavuza wesibeletho, umdlavuza we-ovari, i-endometriosis, noma i-uterine fibroids: I-Resveratrol ingasebenza njenge-estrogen. Uma unanoma isiphi isimo esingahle senziwe sibi ngokuvezwa yi-estrogen, ungasebenzisi i-resveratrol.

Ukuhlinzwa: I-Resveratrol ingakhuphula ingozi yokopha ngesikhathi nangemva kokuhlinzwa. Yeka ukusebenzisa i-resveratrol okungenani amasonto ama-2 ngaphambi kokuhlinzwa okuhleliwe.

Maphakathi
Qaphela ngale nhlanganisela.
Imithi ishintshwe yisibindi (iziqhekeza zeCytochrome P450 1A1 (CYP1A1))
Eminye imishanguzo iyashintshwa futhi yephulwe isibindi. I-Resveratrol inganciphisa ukuthi isibindi sehla kanjani ngokushesha eminye imithi. Ngokwethiyori, ukuthatha i-resveratrol kanye neminye imithi eyehliswe yisibindi kungakhuphula imiphumela kanye nemiphumela emibi yeminye imithi.

Eminye imithi eshintshwe yisibindi ifaka i-chlorzoxazone, theophylline, ne-bufuralol.
Imithi ishintshwe yisibindi (iziqhekeza zeCytochrome P450 1A2 (CYP1A2))
Eminye imishanguzo iyashintshwa futhi yephulwe isibindi. I-Resveratrol inganciphisa ukuthi isibindi sehla kanjani ngokushesha eminye imithi. Ngokwethiyori, ukuthatha i-resveratrol kanye neminye imithi eyehliswe yisibindi kungakhuphula imiphumela kanye nemiphumela emibi yeminye imithi.

Eminye imithi eshintshwe yisibindi ifaka i-clozapine (Clozaril), i-cyclobenzaprine (Flexeril), i-fluvoxamine (i-Luvox), i-haloperidol (i-Haldol), i-imipramine (i-Tofranil), i-mexiletine (i-Mexitil), i-olanzapine (i-Zyprexa), i-pentazocine (i-Talwin), i-propran ), tacrine (Cognex), zileuton (Zyflo), zolmitriptan (Zomig), nabanye.
Imithi ishintshwe yisibindi (iziqhekeza zeCytochrome P450 1B1 (CYP1B1))
Eminye imishanguzo iyashintshwa futhi yephulwe isibindi. I-Resveratrol inganciphisa ukuthi isibindi sehla kanjani ngokushesha eminye imithi. Ngokwethiyori, ukuthatha i-resveratrol kanye neminye imithi eyehliswe yisibindi kungakhuphula imiphumela kanye nemiphumela emibi yeminye imithi.

Eminye imithi eshintshwe yisibindi ihlanganisa i-theophylline, i-omeprazole, i-clozapine, i-progesterone, i-lansoprazole, i-flutamide, i-oxaliplatin, i-erlotinib ne-caffeine.
Imithi ishintshwe yisibindi (iziqhekeza zeCytochrome P450 2C19 (CYP2C19))
Eminye imishanguzo iyashintshwa futhi yephulwe isibindi. I-Resveratrol inganciphisa ukuthi isibindi sehla kanjani ngokushesha eminye imithi. Ngokwethiyori, ukuthatha i-resveratrol kanye neminye imithi eyehliswe yisibindi kungakhuphula imiphumela kanye nemiphumela emibi yeminye imithi.

Eminye imithi eshintshwe yisibindi ihlanganisa i-amitriptyline (Elavil), i-carisoprodol (i-Soma), i-citalopram (i-Celexa), i-diazepam (i-Valium), i-lansoprazole (i-Prevacid), i-omeprazole (i-Prilosec), i-phenytoin (i-Dilantin), i-warfarin neminye eminingi.
Imithi ishintshwe yisibindi (iziqhekeza zeCytochrome P450 2E1 (CYP2E1))
Eminye imishanguzo iyashintshwa futhi yephulwe isibindi. I-Resveratrol inganciphisa ukuthi isibindi sehla kanjani ngokushesha eminye imithi. Ngokwethiyori, ukuthatha i-resveratrol kanye neminye imithi eyehliswe yisibindi kungakhuphula imiphumela kanye nemiphumela emibi yeminye imithi.

Eminye imithi eshintshwe yisibindi ihlanganisa i-acetaminophen, i-chlorzoxazone (iParafon Forte), i-ethanol, i-theophylline, ne-anesthetics efana ne-enflurane (i-Ethrane), i-halothane (i-Fluothane), i-isoflurane (i-Forane), i-methoxyflurane (i-Penthrane).
Imithi ishintshwe yisibindi (iziqhekeza zeCytochrome P450 3A4 (CYP3A4))
Eminye imishanguzo iyashintshwa futhi yephulwe isibindi. I-Resveratrol inganciphisa ukuthi isibindi sehla kanjani ngokushesha eminye imithi. Ngokwethiyori, ukuthatha i-resveratrol kanye neminye imithi eyehliswe yisibindi kungakhuphula imiphumela kanye nemiphumela emibi yeminye imithi. Kodwa-ke, olunye ucwaningo lwakuqala lukhombisa imiphumela ephikisanayo.

Eminye imishanguzo eshintshwe yisibindi ifaka ezinye izigaxa ze-calcium channel (diltiazem, nicardipine, verapamil), ama-chemotherapeutic agents (etoposide, paclitaxel, vinblastine, vincristine, vindesine), ama-antifungals (ketoconazole, itraconazole), glucocorticoids, alfentanil (Alfentaide) ), fentanyl (Sublimaze), lidocaine (Xylocaine), losartan (Cozaar), fexofenadine (Allegra), midazolam (Versed), nabanye.
Imithi eyehlisa ukunqamuka kwegazi (Anticoagulant / Antiplatelet drug)
I-Resveratrol inganciphisa ukuvalwa kwegazi. Ukuthatha i-resveratrol kanye nemithi futhi eyehlisa kancane ukuvimba kungandisa amathuba okulimala nokopha.

Eminye imishanguzo eyehlisa ijubane ukuvala igazi ifaka phakathi i-aspirin, i-clopidogrel (i-Plavix), i-diclofenac (i-Voltaren, i-Cataflam, abanye), i-ibuprofen (i-Advil, i-Motrin, abanye), i-naproxen (i-Anaprox, i-Naprosyn, abanye), i-dalteparin (i-Fragmin), i-enoxaparin (i-Lovenox) , heparin, warfarin (Coumadin), nabanye.
Amakhambi nezengezo ezinganciphisa ukujiya kwegazi (Anticoagulant / Antiplatelet herbs and supplements)
I-Resveratrol inganciphisa ukuvalwa kwegazi. Ukuyisebenzisa kanye namanye amakhambi noma izithasiselo ezinganciphisa nokuqina kwegazi kungakhuphula ingozi yokuphuma kwegazi noma ukulimaza kwabanye abantu. Lawa makhambi afaka i-angelica, i-clove, i-danshen, i-feverfew, i-garlic, i-ginger, i-ginkgo, i-ginseng Panax, i-chestnut yamahhashi, i-red clover, i-turmeric, nezinye.
Amafutha nokudla okuqukethe amafutha
Ukuthatha i-resveratrol ngesidlo esinamafutha amaningi kunganciphisa inani le-resveratrol elimuncwa umzimba.
Imithamo elandelayo ifundwe ocwaningweni lwesayensi:

ABADALA

NGOMLOMO:
  • Ngezinkinga zomzimba ezithile zonyaka (hay fever): Izifutho ezimbili ze-0.1% resveratrol nasal spray ekhaleni ngalinye kathathu / ngosuku kuze kube amasonto amane.
  • Okokukhuluphala: 500 mg noma ngaphansi kwe-resveratrol nsuku zonke izinyanga ezintathu noma ngaphezulu.
3,5,4 'TriHydroxy-Transstibene, (E) - 5- (4-hydroxystyryl) benzene-1,3-diol, 3,4', 5-stilbenetriol, 3,5,4 '-trihydroxystilbene, 3,4 ', 5-trihydroxystilbene, 3,5,4'-trihydroxy-trans-stilbene, Cis-Resveratrol, Extrait de Vin, Extrait de Vin Rouge, Kojo-Kon, Phytoalexin, Phytoalexine, Phytoestrogen, Phyto-œstrogène, Pilule de Vin, I-Protykin, i-Red Wine extract, i-Resvératrol, i-Resveratrols, i-Resvératrols, i-RSV, i-RSVL, i-Stilbene Phytoalexin, i-Trans-Resveratrol, iTrans-Resvératrol, i-Wine Extract, i-Pill yewayini.

Ukuze ufunde kabanzi ngokuthi le ndatshana ibhalwe kanjani, sicela ubheke ifayela le- Imibhalo Yemvelo Yemininingwane Ephelele indlela.


  1. UZhang N, Liang T, Jin Q, Shen C, Zhang Y, Jing P. Chinese yam (Dioscorea opposita Thunb.) Unciphisa isifo sohudo esihambisana nemithi elwa namagciwane, ushintsha i-microbiota yamathumbu, futhi andise izinga lama-acid fatty chain kumagundane. Ukudla Res Int. 2019; 122: 191-198. Buka okungaqondakali.
  2. U-Akbari M, Tamtaji OR, uLankarani KB, et al. Imiphumela ye-resveratrol supplementation ekusebenzeni kwe-endothelial kanye nengcindezi yegazi phakathi kweziguli ezine-metabolic syndrome kanye nokuphazamiseka okuhlobene: ukubuyekezwa okuhlelekile nokuhlaziywa kwemeta kwezilingo ezilawulwa ngokungahleliwe. I-High Press Press Cardiovasc Prev 2019; 26: 305-19. Buka okungaqondakali.
  3. UKöbe T, uWitte AV, uSchnelle A, et al. Umthelela we-resveratrol ekulawuleni i-glucose, isakhiwo se-hippocampal nokuxhuma, nokusebenza kwememori ezigulini ezinokukhubazeka okuncane kwengqondo. Ngaphambili Neurosci 2017; 11: 105. Buka okungaqondakali.
  4. I-Witte AV, i-Kerti L, i-Margulies DS, i-Flöel A. Imiphumela ye-resveratrol ekusebenzeni kwememori, ukuxhumeka kokusebenza kwe-hippocampal, kanye ne-glucose metabolism kubantu abadala abaphilile. UJ Neurosci 2014; 34: 7862-70. Buka okungaqondakali.
  5. UMousavi SM, uMilajerdi A, uSheikhi A, et al. Ukwengezwa kwe-Resveratrol kuthonya kakhulu izindlela zokukhuluphala: ukubuyekezwa okuhlelekile kanye nokuhlaziywa kwemethamo yokuphendula imethamo yezilingo ezilawulwa ngokungahleliwe. Obes Rev 2019; 20: 487-98. Buka okungaqondakali.
  6. I-Sattarinezhad A, Roozbeh J, Shirazi Yeganeh B, Omrani GR, Shams M. Resveratrol inciphisa i-albuminuria ku-nephropathy yesifo sikashukela: isilingo somtholampilo esilawulwa ngokungahleliwe. Isifo Sikashukela Metab 2019; 45: 53-9. Buka okungaqondakali.
  7. UZhang C, Yuan W, Fang J, Wang W, He P, Lei J, Wang C. Ukusebenza kwe-Resveratrol Supplementation ngokumelene ne-Non-Alcoholic Fatty Liver Disease: I-Meta-Analysis ye-Placebo-Controlled Clinical Trials. Ama-PLoS One. 2016 Aug 25; 11: e0161792. Buka okungaqondakali.
  8. UPoulsen MK, uNellemann B, uBibby BM, et al. Awukho umthelela we-resveratrol ku-VLDL-TG kinetics nokuzwela kwe-insulin emadodeni akhuluphele kakhulu anesifo sesibindi esinamafutha angenalo utshwala. Isifo Sikashukela Obes Metab. 2018; 20: 2504-2509. Buka okungaqondakali.
  9. UHussain SA, uMarouf BH, u-Ali ZS, u-Ahmmad RS. Ukusebenza nokuphepha kokubambisana kokubambisana kwe-resveratrol ne-meloxicam ezigulini ezine-knee osteoarthritis: isifundo sokungenelela somshayeli. Ukuguga Kwe-Clin Interv. 2018; 13: 1621-1630. Buka okungaqondakali.
  10. UHuhn S, uBeyer F, uZhang R, et al. Imiphumela ye-resveratrol ekusebenzeni kwememori, ukuxhumeka kwe-hippocampus kanye nokwakheka kwezinto ezincane kubantu abadala - Isivivinyo esilawulwa ngokungahleliwe. I-Neuroimage. 2018; 174: 177-190. Buka okungaqondakali.
  11. UHaghpanah S, uZarei T, u-Eshghi P, et al. Ukusebenza nokuphepha kwe-resveratrol, i-agent ye-hemoglobin yomlomo yokwandisa i-F, ezigulini ezine-beta-thalassemia intermedia. U-Ann Hematol. 2018; 97: 1919-1924. Buka okungaqondakali.
  12. U-Anton SD, u-Ebner N, Dzierzewski JM, et al. Imiphumela Yezinsuku ezingama-90 ze-Resveratrol Supplementation ku-Cognitive Function in Elders: A Pilot Study. UJ Altern Complement Med. 2018; 24: 725-732. Buka izifushaniso.
  13. I-Lv C, i-Zhang Y, i-Shen L. Ukuhlolwa kokuqala komtholampilo kwe-resveratrol kubantu abadala abane-allergen rhinitis. I-Int Arch yokungezwani komzimba ne-Immunol 2018; 175: 231-6. Buka okungaqondakali.
  14. UZortea K, uFranco VC, uFrancesconi LP, uCereser KM, uLobato MI, iBelmonte-de-Abreu PS. I-Resveratrol Supplementation in Iziguli ZeSchizophrenia: Isivivinyo Somtholampilo Esingahleliwe Esihlola I-Serum Glucose kanye Nezici Zeengozi Zenhliziyo. Izakhamzimba. 2016; 8: 73. Buka okungaqondakali.
  15. UWightman EL, uHaskell-Ramsay CF, uRayay JL, et al. Imiphumela yokwengeza okungapheli kwe-trans-resveratrol ezicini zomsebenzi wokuqonda, imizwa, ukulala, impilo nokugeleza kwegazi kobuchopho kubantu abaphilile, abasha. UBr J Nutriti. 2015; 114: 1427-37. Buka okungaqondakali.
  16. I-Turner RS, uThomas RG, uCraft S, et al. Isilingo esilawulwa ngokungahleliwe, esingaboni kabili, esilawulwa nge-placebo se-resveratrol sesifo i-Alzheimer. Neurology. 2015; 85: 1383-91. Buka okungaqondakali.
  17. Ama-Timmers S, de Ligt M, uPhielix E, et al. I-Resveratrol njengokwelashwa okungeziwe ezihlokweni ezinesifo sikashukela sohlobo 2 esilawulwa kahle: Isivivinyo esilawulwa ngokungahleliwe. Ukunakekelwa yisifo sikashukela. 2016; 39: 2211-2217. Buka okungaqondakali.
  18. USamsami-Kor M, uDaryani NE, u-Asl PR, uHekmatdoost A. Imiphumela Emelene Nokuvuvukala YeResveratrol ezigulini ezine-Ulcerative Colitis: Isifundo Esilawulwa Ngezindiza Esilawulwa Ngokungahleliwe, Esiphindiwe, Esilawulwa Ngeplacebo. I-Arch Med Res. 2015; 46: 280-5. Buka okungaqondakali.
  19. ILin CT, iLanga XY, iLin AX. Ukwengezwa nge-high-dose trans-resveratrol kuthuthukisa ukuhlelwa kabusha kweziguli ze-peritoneal dialysis: isifundo esizayo, esingahleliwe, esiyimpumputhe. URen Fail. 2016; 38: 214-21. Buka okungaqondakali.
  20. UKjaer TN, u-Ornstrup MJ, uPoulsen MM, et al. I-Resveratrol inciphisa amazinga wokujikeleza kwe-androgen precursors kepha ayinamphumela ku-testosterone, dihydrotestosterone, PSA amazinga noma ivolumu ye-prostate. Isivivinyo sezinyanga ezi-4 esingahleliwe emadodeni aphakathi nendawo. Indlala yesinye. 2015; 75: 1255-63. Buka okungaqondakali.
  21. U-Evans HM, uHowe PR, uWong RH. Imiphumela yeResveratrol ekusebenzeni kwengqondo, Mood kanye neCerebrovascular Function ku-Post-Menopausal Women; Isivivinyo Sokungenelela Esilawulwa Indawo Esilawulwa Ngokulawulwa Kwamasonto Ayishumi nane. Izakhamzimba. 2017; 9. Buka okungaqondakali.
  22. U-Elgebaly A, uRadwan IA, u-AboElnas MM, et al. I-Resveratrol Supplementation ezigulini ezinesifo esingesona esinotshwala esinamafutha wesibindi: Ukubuyekezwa okuhlelekile nokuhlaziywa kwe-Meta. J Gastrointestin Isibindi Dis. 2017; 26: 59-67.Buka okungaqondakali.
  23. UBo S, uPonzo V, uCiccone G, et al. Izinyanga eziyisithupha zokuxhaswa nge-resveratrol akunamphumela olinganisekayo ezigulini zesifo sikashukela sohlobo 2. Isilingo esilawulwa ngokungahleliwe, esiyimpumputhe kabili, esilawulwa yi-placebo. IPharmacol Res. 2016; 111: 896-905. Buka okungaqondakali.
  24. IBedada SK, Neerati P. Resveratrol Pretreatment Ithinta Umsebenzi we-CYP2E1 we-Chlorzoxazone kumaVolontiya Abantu Abaphilile. I-Phytother Res. 2016; 30: 463-8. Buka okungaqondakali.
  25. Banaszewska B, Wrotynska-Barczynska J, Spaczynski RZ, Pawelczyk L, Duleba AJ. Imiphumela yeResveratrol kwiPolycystic Ovary Syndrome: Isivivinyo esilawulwa kabili, esingahleliwe, esilawulwa yiPlacebo. UJ Clin Endocrinol Metab. 2016; 101: 4322-4328. Buka okungaqondakali.
  26. UKhojah HM, u-Ahmed S, u-Abdel-Rahman MS, u-Elhakeim EH. I-Resveratrol njengokwelashwa okusebenzayo kwe-adjuvant ekuphathweni kwe-rheumatoid arthritis: isifundo somtholampilo. Umtholampilo Rheumatol. 2018; [I-Epub ngaphambi kokuphrinta]. Buka okungaqondakali.
  27. UShishodia S, u-Aggarwal BB. I-Resveratrol: i-polyphenol yazo zonke izinkathi zonyaka. Resveratrol kwezempilo kanye nezifo. IBoca Raton, FL: ICC Press, 2005.
  28. ICreasy LL, ikhofi lokukhiqiza ikhofi M. Phytoalexin lamajikijolo wamagilebhisi. UJ Am Soc Hortic Sci. 1988; 113: 230-234.
  29. I-Langcake P, uMcCarthy W. Ubudlelwano bokukhiqizwa kwe-resveratrol nokutheleleka kwamaqabunga omvini nguBotrytis cinerea. I-Vitis. 1979; 18: 244-253.
  30. Intengo NL, Gomes AP, Ling AJ, Duarte FV, Martin-Montalvo A, North BJ, Agarwal B, Ye L, Ramadori G, Teodoro JS, Hubbard BP, Varela AT, Davis JG, Varamini B, Hafner A, Moaddel R, Rolo AP, Coppari R, Palmeira CM, de Cabo R, Baur JA, Sinclair DA. I-SIRT1 iyadingeka ekusebenzeni kwe-AMPK kanye nemiphumela ezuzisayo ye-resveratrol emsebenzini we-mitochondrial. Iseli Metab. 2012 Meyi 2; 15: 675-90. Buka okungaqondakali.
  31. U-Wang S, Moustaid-Moussa N, Chen L, Mo H, Shastri A, Su R, Bapat P, Kwun I, Shen CL. Imininingwane yenoveli yama-polyphenols wokudla nokukhuluphala. J Amakhemikhali Amakhemikhali. 2014 Jan; 25: 1-18. Buka okungaqondakali.
  32. Palamara AT, Nencioni L, Aquilano K, De Chiara G, Hernandez L, Cozzolino F, Ciriolo MR, Garaci E. Ukuvinjelwa komkhuhlane Ukuphindaphindeka kwegciwane nge-resveratrol. J Ukutheleleka Dis. 2005 Meyi 15; 191: 1719-29. Buka okungaqondakali.
  33. UMastromarino P, uCapobianco D, uCannata F, uNardis C, uMattia E, uDe Leo A, uRestignoli R, uFrancioso A, uMosca L.Reververrol ivimbela ukuphindaphindeka kwe-rhinovirus kanye nokuvezwa kwabalamuli abavuthayo e-nasal epithelia. Amagciwane Res. 2015 Nov; 123: 15-21. Buka okungaqondakali.
  34. UCrowell JA, uKorytko PJ, uMorrissey RL, uBooth TD, uLevine BS. I-Resveratrol-ehambisana nobuthi bezinso. I-Toxicol Sci. 2004 Dis; 82: 614-9. Buka okungaqondakali.
  35. Semba RD, Ferrucci L, Bartali B, Urpí-Sarda M, Zamora-Ros R, Sun K, Cherubini A, Bandinelli S, Andres-Lacueva C. Amazinga eReververrol nakho konke okudala ukufa kwabantu abadala asebekhulile abahlala emiphakathini. I-JAMA Intern Med. 2014 Julayi; 174: 1077-84. Buka okungaqondakali.
  36. I-Sahebkar A. Imiphumela yokwengezwa kwe-resveratrol kuma-lipids e-plasma: ukubuyekezwa okuhlelekile nokuhlaziywa kwemeta kwezilingo ezilawulwa ngokungahleliwe. Umsoco IsAm. 2013 Dec; 71: 822-35. Buka okungaqondakali.
  37. UMiraglia Del Giudice M, Maiello N, Capristo C, Alterio E, Capasso M, Perrone L, Ciprandi G. Resveratrol kanye ne-carboxymethyl-ß-glucan kunciphisa izimpawu zamakhala ezinganeni ezine-pollen-induced allergen rhinitis. I-Curr Med Res Opin. 2014 Okthoba; 30: 1931-5. Buka okungaqondakali.
  38. UMéndez-del Villar M, uGonzález-Ortiz M, uMartínez-Abundis E, uPérez-Rubio KG, uLizárraga-Valdez R. Umphumela wokuphathwa kwe-resveratrol ku-syndrome ye-metabolic, ukuzwela kwe-insulin, nokugcinwa kwe-insulin. Imetab Syndr Relat Disord. 2014 Dis; 12: 497-501. Buka okungaqondakali.
  39. Magyar K, Halmosi R, Palfi A, Feher G, Czopf L, Fulop A, Battyany I, Sumegi B, Toth K, Szabados E. Cardioprotection by resveratrol: Isivivinyo somtholampilo womuntu ezigulini ezinesifo somthambo we-coronary ozinzile. Umtholampilo Hemorheol Microcirc. 2012; 50: 179-87. Buka okungaqondakali.
  40. U-Liu K, uZhou R, uWang B, uMi MT. Umphumela we-resveratrol ekulawuleni i-glucose nokuzwela kwe-insulin: ukuhlaziywa kwe-meta kokuhlolwa okungu-11 okulawulwa ngokungahleliwe. Ngingu-J J Nutriti Womtholampilo. 2014 Juni; 99: 1510-9. Buka okungaqondakali.
  41. UFaghihzadeh F, Adibi P, Rafiei R, Hekmatdoost A.Resveratrol supplementation ithuthukisa ama-biomarkers okuvuvukala ezigulini ezinesifo esingenamafutha esinesibindi. I-Nut Nut. 2014 Okthoba; 34: 837-43. Buka okungaqondakali.
  42. UChachay VS, Macdonald GA, Martin JH, Whitehead JP, O'Moore-Sullivan TM, Lee P, Franklin M, Klein K, Taylor PJ, Ferguson M, Coombes JS, Thomas GP, Cowin GJ, Kirkpatrick CM, Prins JB, Hickman IJ. I-Resveratrol ayizisizi iziguli ezinezifo zesibindi ezinamafutha ezingekho utshwala. Umtholampilo Gastroenterol Hepatol. 2014 Dis; 12: 2092-103.e1-6. Buka okungaqondakali.
  43. Hudson, GM, Shelmadine, B., Cooke, M., Genovese, J., Greenwood, M., noWilloughby, DS Resveratrol Supplementation And Changes In Glucose, Insulin, And mRNA Expression Following Exercise In Overweight Abesifazane: 2467. Imithi & Isayensi Kwezemidlalo Nokuzivocavoca 2011; 43
  44. UGuarnieri, R., uPappacoda, A., noSolitro, S. [I-resveratrol equkethe i-compound inciphisa ukucindezeleka okwenziwe nge-oxidative futhi yenza ngcono izimpawu zomtholampilo ezifundweni ze-COPD] Un composto a base di resveratrolo riduce lo stress ossidativo e migliora la sintomatologia clinica in soggetti con BPCO . ICochrane Central Register Yezilingo Ezilawulwayo 2009;
  45. UYoon, SJ, Cho, KS, Lee, YH, Kim, DS, noHong, SJ RESVERATROL INHIBITS CXCR4 MEDIATED TUMOR GROWTH AND FIGGATION OF HUMAN KIDNEY CERER CELL IN VITRO AND VIVO: 428. Ijenali ye-Urology 2009; 181: 153- 154.
  46. UKlink, JC, Poulton, S., Antonelli, J., Potter, MQ, Jayachandran, J., Tewari, AK, Febbo, PG, Pizzo, SV, noFreedland, S. RESVERATROL ALTERS PROSTATE CANCER XENOGRAFT UKUKHULA: 724. Journal kwe-Urology 2009; 181
  47. Ngokusobala, uK. A. Cannabinoid receptor inverse agonists njengama-ejenti wezokwelapha amasha. "I-Sciences and Engineering. I-Sciences and Engineering 2009; 70 (4-B)
  48. Pregliasco, F. and Cogo, R. [Antioxidant kanye ne-immunomodulating compounds kubantu asebekhulile abagonyelwa umkhuhlane wonyaka bathuthukisa ukusabela kwe-serological futhi banciphise iziqephu zokuphefumula] L'uso di sostanze antiossidanti ed immunomodulanti in una popolazione anziana so. ICochrane Central Register Yezilingo Ezilawulwayo 2010;
  49. USteigerwald, M. D., Fisk, M. Z., Smoliga, J. M., noRundell, K. W. Imiphumela YeResveratrol Ekucindezelekeni Kwe-Oxidative Nasemsebenzini We-Vascular Ngemuva Kokuzivocavoca Ekungcolisweni Komoya Okulingisiwe: 2645. Imithi Nezesayensi Kwezemidlalo Nokuzivocavoca 2011;
  50. I-Bost, J., Smoliga, JM, Bost, KM, neMaroon, i-JC Izinyanga Ezintathu Zokwengezelelwa Komlomo kwe-Unique Polyphenol Inhlanganisela Ithuthukisa Izinkomba Zokusebenza Zomzimba Ne-Neurocognitive Kwabantu Abangamahlalakhona: 2205. Imithi & Isayensi Kwezemidlalo Nokuzivocavoca 2008; 40: S246 .
  51. UGrujic Milanovic, J., Mihailovic-Stanojevic, N., Miloradovic, Z., Jacevic, V., Milosavljevic, I., Milanovic, S., Ivanov, M., noJovovic, DJ RESVERATROL WENZA UKUCindezelwa Kwegazi, IZINGUQUKO ZE-ANTIOXIDANT UMSEBENZI WE-ENZYME NE-PARAMETERS ZOMLANDO KWISIMISO SOKUHLOLA SE-MALIGNANT HYPERTENSION PP.29.171. Ijenali Yehypertension 2010; 28
  52. UPendurthi, U. R., Williams, J. T., noRao, L. V. Resveratrol, inhlanganisela ye-polyphenolic etholakala ewayinini, ivimbela ukubonakaliswa kwezicubu kumaseli emithambo yegazi: Indlela engenzeka yezinzuzo zenhliziyo ezihambisana nokusetshenziswa ngokulinganisela kwewayini. I-Arterioscler.Ibhomu.Vasc. Biol 1999; 19: 419-426. Buka okungaqondakali.
  53. URotondo, S., Rajtar, G., Manarini, S., Celardo, A., Rotillo, D., de Gaetano, G., Evangelista, V., noCerletti, C. Umphumela we-trans-resveratrol, i-polyphenolic yemvelo ihlanganisiwe, ekusebenzeni komuntu kwe-polymorphonuclear leukocyte. UBr. J. Pharmacol. 1998; 123: 1691-1699. Buka okungaqondakali.
  54. UBhatt, J. K., Thomas, S., noNanjan, M. J. Resveratrol supplementation kuthuthukisa ukulawulwa kwe-glycemic kuhlobo lwe-2 yesifo sikashukela. Ukudla okunomsoco. 2012; 32: 537-541. Buka okungaqondakali.
  55. UHector, K. L., Lagisz, M., noNakagawa, S. Umphumela we-resveratrol kubude besikhathi eside kuzo zonke izinhlobo zezinto eziphilayo: ukuhlaziywa kwemeta. Umlando. 10-23-2012; 8: 790-793. Buka okungaqondakali.
  56. URoehr, B. Umcwaningi wenhliziyo uqambe imininingwane ezifundweni zewayini elibomvu. BMJ 2012; 344: e406. Buka okungaqondakali.
  57. Crandall, J. P., Oram, V., Trandafirescu, G., Reid, M., Kishore, P., Hawkins, M., Cohen, H. W., noBarzilai, N. Pilot ukutadisha i-resveratrol kubantu abadala asebekhulile abane-glucose ukubekezelelana okungalungile. JGerontol.I-Biol.Sci.Med.Sci. 2012; 67: 1307-1312. Buka okungaqondakali.
  58. Fujitaka, K., Otani, H., Jo, F., Jo, H., Nomura, E., Iwasaki, M., Nishikawa, M., Iwasaka, T., kanye ne-Das, DK Modified resveratrol Longevinex ithuthukisa ukusebenza kwe-endothelial kubantu abadala abane-syndrome ye-metabolic abathola ukwelashwa okujwayelekile. Umsoco. 2011; 31: 842-847. Buka okungaqondakali.
  59. Isikhathi, S., Konings, E., Bilet, L., Houtkooper, RH, van de Weijer, T., Goossens, GH, Hoeks, J., van der Krieken, S., Ryu, D., Kersten, S ., Moonen-Kornips, E., Hesselink, MK, Kunz, I., Schrauwen-Hinderling, VB, Blaak, EE, Auwerx, J., noSchrauwen, P. imiphumela efana nemingcele ye-Calorie yezinsuku ezingama-30 zokuxhaswa kwe-resveratrol ku imetabolism yamandla kanye nephrofayili yemethabolikhi kubantu abakhuluphele. Iseli Metab 11-2-2011; 14: 612-622. Buka okungaqondakali.
  60. U-Xuzhu, G., Komai-Koma, M., Leung, B. P., Howe, H. S., McSharry, C., McInnes, I. B., no-Xu, D. I-Resveratrol modulates i-murine collagen-induced arthritis ngokuvimbela ukusebenza kwe-Th17 ne-B-cell. U-Ann.Rheum. Dis 2012; 71: 129-135. Buka okungaqondakali.
  61. Knight, CM, Gutierrez-Juarez, R., Lam, TK, Arrieta-Cruz, I., Huang, L., Schwartz, G., Barzilai, N., noRossetti, L. Mediobasal hypothalamic SIRT1 kubalulekile emiphumeleni ye-resveratrol esenzweni se-insulin kumagundane. Isifo sikashukela 2011; 60: 2691-2700. Buka okungaqondakali.
  62. Howells, LM, Berry, DP, Elliott, PJ, Jacobson, EW, Hoffmann, E., Hegarty, B., Brown, K., Steward, WP, and Gescher, AJ Phase I randomized, double-blind study pilot of micronized i-resveratrol (i-SRT501) ezigulini ezine-hepatic metastases - ukuphepha, i-pharmacokinetics, ne-pharmacodynamics. I-Cancer Prev. Res (Phila) 2011; 4: 1419-1425. Buka okungaqondakali.
  63. Wuertz, K., Quero, L., Sekiguchi, M., Klawitter, M., Nerlich, A., Konno, S., Kikuchi, S., and Boos, N. Iwayini elibomvu i-polyphenol resveratrol ikhombisa amandla ethembisayo ukwelashwa kobuhlungu be-nucleus pulposus-Mediated in vitro naku-vivo. Umqolo (Phila Pa 1976.) 10-1-2011; 36: E1373-E1384. Buka okungaqondakali.
  64. Brasnyo, P., Molnar, GA, Mohas, M., Marko, L., Laczy, B., Cseh, J., Mikolas, E., Szijarto, IA, Merei, A., Halmai, R., Meszaros, I-LG, Sumegi, B., neWittmann, I. I-Resveratrol ithuthukisa ukuzwela kwe-insulin, inciphisa ukucindezeleka okwenziwe nge-oxidative futhi isebenzise indlela ye-Akt kuhlobo lwesibili lweziguli ezinesifo sikashukela. UBr J Nutriti. 2011; 106: 383-389. Buka okungaqondakali.
  65. UFabbrocini, G., Staibano, S., De, Rosa G., Battimiello, V., Fardella, N., Ilardi, G., La Rotonda, MI, Longobardi, A., Mazzella, M., Siano, M. , Pastore, F., De, Vita, V, Vecchione, ML, no-Ayala, F. I-gel ene-Resveratrol yokwelapha i-acne vulgaris: isifundo sokushayela indiza esisodwa esingaboni, esilawulwa yimoto. NginguJ J Clin. EDermatol 4-1-2011; 12: 133-141. Buka okungaqondakali.
  66. Kitada, M., Kume, S., Imaizumi, N., noKoya, D.I-Resveratrol ithuthukisa ukucindezeleka kwe-oxidative futhi ivikele ekulweni nephropathy yesifo sikashukela ngokwenza ukujwayeleka kokungasebenzi kahle kwe-Mn-SOD ku-AMPK / SIRT1-Independent pathway. Isifo sikashukela 2011; 60: 634-643. Buka okungaqondakali.
  67. Shindler, K. S., Ventura, E., Dutt, M., Elliott, P., Fitzgerald, D. C., noRostami, A. I-Orver resveratrol inciphisa ukulimala kwe-neuronal kwimodeli ye-multiple sclerosis. UJ Neuroophthalmol. 2010; 30: 328-339. Buka okungaqondakali.
  68. UBrown, VA, Patel, KR, Viskaduraki, M., Crowell, JA, Perloff, M., Booth, TD, Vasilinin, G., Sen, A., Schinas, AM, Piccirilli, G., Brown, K.,. Steward, WP, Gescher, AJ, and Brenner, DE Phinda ucwaningo lwesilinganiso somdlavuza we-chemopreventive agent resveratrol kumavolontiya anempilo: ukuphepha, i-pharmacokinetics, kanye nomphumela we-insulin-like factor factor axis. Umdlavuza Res 11-15-2010; 70: 9003-9011. Buka okungaqondakali.
  69. UPatel, KR, Brown, VA, Jones, DJ, Britton, RG, Hemingway, D., Miller, AS, West, KP, Booth, TD, Perloff, M., Crowell, JA, Brenner, DE, Steward, WP, UGescher, AJ, noBrown, K. I-Clinical pharmacology ye-resveratrol kanye nama-metabolite ayo ezigulini ezinomdlavuza onamandla. ICancer Res 10-1-2010; 70: 7392-7399. Buka okungaqondakali.
  70. Knobloch, J., Sibbing, B., Jungck, D., Lin, Y., Urban, K., Stoelben, E., Strauch, J., noKoch, A. Resveratrol kuphazamisa ukukhishwa kwama-cytokines amelana nokuvuvukala kwama-steroid. kusuka kumangqamuzana omuntu wemisipha abushelelezi esifo esingamahlalakhona se-pulmonary disease. J Pharmacol. Ukuchazwa. 2010; 335: 788-798. Buka okungaqondakali.
  71. I-Chow, HH, Garland, LL, Hsu, CH, Vining, DR, Chew, WM, Miller, JA, Perloff, M., Crowell, JA, ne-Alberts, i-DS Resveratrol modulates enzymes yezidakamizwa neye-carcinogen kumavolontiya anempilo funda. Umdlavuza Wangaphambilini. Res (Phila) 2010; 3: 1168-1175. Buka okungaqondakali.
  72. Wong, R.H, Howe, P. R., Buckley, J. D., Coates, A. M., Kunz, I., noBerry, N. M. Acute resveratrol supplementation kuthuthukisa ukugeleza okugeleza okugeleza kwabantu abakhuluphele / abakhuluphele kakhulu abanomfutho wegazi ophakeme. Umuthi Metab Cardiovasc. Dis 2011; 21: 851-856. Buka okungaqondakali.
  73. la, Porte C., Voduc, N., Zhang, G., Seguin, I., Tardiff, D., Singhal, N., noCameron, DW Steady-State pharmacokinetics nokubekezelelana kwe-trans-resveratrol 2000 mg kabili nsuku zonke nge ukudla, i-quercetin notshwala (i-ethanol) ezifundweni zabantu ezinempilo. Umtholampilo Pharmacokinet. 2010; 49: 449-454. Buka okungaqondakali.
  74. I-Le Couteur, i-D.G ne-Sinclair, i-D.A ipulani yokwakha izindlela zokwelapha ezandisa impilo kanye nokubambezela ukufa. J Gerontol. I-Biol. Isayensi. I-Med Sci. 2010; 65: 693-694. Buka okungaqondakali.
  75. UKennedy, DO, Wightman, EL, Reay, JL, Lietz, G., Okello, EJ, Wilde, A., noHaskell, Imiphumela ye-CF yokuphindisela emuva ekuguqukeni kwegazi lobuchopho nokusebenza kwengqondo kubantu: i-placebo engaboni kabili. -ukulawulwa, uphenyo lwe-crossover. NginguJ J Clin. 2010; 91: 1590-1597. Buka okungaqondakali.
  76. UDaffner, K. R. Ukukhuthaza ukuguga okuphumelelayo kwengqondo: ukubuyekeza okuphelele. J Ama-Alzheimers. Dis 2010; 19: 1101-1122. Buka okungaqondakali.
  77. Yu, H. P., Hwang, T. L., Hwang, T. L., Yen, C.H, noLau, Y.T.Resveratrol ivimbela ukungasebenzi kahle kwe-endothelial kanye nokukhiqizwa kwe-aortic superoxide ngemuva kokwehla kwegazi lokuhlukumezeka ngokusebenzisa i-estrogen receptor-based hemeoxygenase-1 pathway. ICrit Care Med 2010; 38: 1147-1154. Buka okungaqondakali.
  78. U-Albani, D., Polito, L., no-Forloni, G. Sirtuins njengezinjongo zenoveli zesifo i-Alzheimer nezinye izifo ze-neurodegenerative: ubufakazi bokuhlola nobofuzo. J Ama-Alzheimers. Dis 2010; 19: 11-26. Buka okungaqondakali.
  79. UGuo, J. P., Yu, S., noMcGeer, P. L. Izilingo ezilula ze-vitro zokuhlonza ama-amyloid-beta aggregation blockers e-Alzheimer's's therapy. J Ama-Alzheimers. Dis. 2010; 19: 1359-1370. Buka okungaqondakali.
  80. UJha, R. K., Ma, Q., Sha, H., noPalikhe, M. Umphumela wokuvikela we-resveratrol ekulimaleni okunamandla okubangelwa yi-pancreatitis. Amapancreas 2009; 38: 947-953. Buka okungaqondakali.
  81. UZhang, H., Zhang, J., Ungvari, Z., noZhang, C. I-Resveratrol ithuthukisa ukusebenza kwe-endothelial: indima ye-TNF {alpha} kanye nengcindezi ye-oxidative ye-vascular. I-Arterioscler.Ibhomu.Vasc.Ibhayisikili. U-2009; 29: 1164-1171. Buka okungaqondakali.
  82. I-Bournival, J., Quessy, P., noMartinoli, M. G. Imiphumela yokuvikela i-resveratrol ne-quercetin emelene nesenzo sokuxineka okwenziwe nge-MPP + ngokuguqula izimpawu zokufa kwe-apoptotic kuma-dopaminergic neurons. Iseli Mol. Neurobiol. U-2009; 29: 1169-1180. Buka okungaqondakali.
  83. U-Almeida, L., Vaz-da-Silva, M., Falcao, A., Soares, E., Costa, R., Loureiro, AI, Fernandes-Lopes, C., Rocha, JF, Nunes, T., Wright , L., and Soares-da-Silva, P. Pharmacokinetic and safety profile of trans-resveratrol esifundweni esikhuphuka semithamo eminingi kumavolontiya anempilo. I-Mol.Nutr.Food Res 2009; 53 iSuppl 1: S7-15. Buka okungaqondakali.
  84. UVingtdeux, V., Dreses-Werringloer, U., Zhao, H., Davies, P., noMambaud, P. Ukwelashwa okungenzeka kube yi-resveratrol ku-Alzheimer's's disease. BMC.Neurosci. 2008; 9 Isengezo 2: S6. Buka okungaqondakali.
  85. UFan, E., Zhang, L., Jiang, S., noBai, Y. Imiphumela ezuzisayo ye-resveratrol ku-atherosclerosis. J Med Ukudla 2008; 11: 610-614. Buka okungaqondakali.
  86. UVaz-da-Silva, M., Loureiro, AI, Falcao, A., Nunes, T., Rocha, JF, Fernandes-Lopes, C., Soares, E., Wright, L., Almeida, L., no I-Soares-da-Silva, P. Umphumela wokudla kuphrofayela ye-pharmacokinetic ye-trans-resveratrol. Int. J Clin. Pharmacol. Ngonyaka ka-2008; 46: 564-570. Buka okungaqondakali.
  87. UDudley, J. I., Lekli, I., Mukherjee, S., Das, M., Bertelli, A. A., noDas, D. K. Ngabe iwayini elimhlophe liyakufanelekela ukuphikisana kweFrance? Ukuqhathaniswa kwemiphumela ye-cardioprotective yewayini elibomvu nelimhlophe nezakhi zalo: i-resveratrol, i-tyrosol, ne-hydroxytyrosol. J Agric. Ukudla Chem. 10-22-2008; 56: 9362-9373. Buka okungaqondakali.
  88. U-Orallo, F. Trans-resveratrol: i-elixir yemilingo yentsha engunaphakade? UMed Chem. 2008; 15: 1887-1898. Buka okungaqondakali.
  89. URocha-Gonzalez, H. I., Ambriz-Tututi, M., noGranados-Soto, V.Resveratrol: indawo eyindalo enamandla emithi ezifweni ze-neurodegenerative. UTher 2008; 14: 234-247. Buka okungaqondakali.
  90. ICalabrese, V., Cornelius, C., Mancuso, C., Pennisi, G., Calafato, S., Bellia, F., Bates, TE, Giuffrida Stella, AM, Schapira, T., Dinkova Kostova, AT, kanye URizzarelli, E. Impendulo yokuxineka kwamaselula: inhloso yenoveli yokwelashwa ngamakhemikhali kanye nokuvikelwa kokudla okunomsoco ekugugeni, ukuphazamiseka kwe-neurodegenerative kanye nokuphila isikhathi eside. I-Neurochem. Res 2008; 33: 2444-2471. Buka okungaqondakali.
  91. Pearson, KJ, Baur, JA, Lewis, KN, Peshkin, L., Intengo, NL, Labinskyy, N., Swindell, WR, Kamara, D., Minor, RK, Perez, E., Jamieson, HA, Zhang, Y., Dunn, SR, Sharma, K., Pleshko, N., Woollett, LA, Csiszar, A., Ikeno, Y., Le Couteur, D., Elliott, PJ, Becker, KG, Navas, P.,. I-Ingram, i-DK, i-Wolf, i-NS, i-Ungvari, i-Z., i-Sinclair, i-DA, ne-de Cabo, i-R. Resveratrol ibambezela ukuwohloka okuhlobene nobudala futhi ilingise izinto ezibhalwe phansi zomkhawulo wokudla ngaphandle kokunweba isikhathi sokuphila. Iseli Metab 2008; 8: 157-168. Buka okungaqondakali.
  92. UDong, W., Li, N., Gao, D., Zhen, H., Zhang, X., noLi, F. Resveratrol kunciphisa ukulimala kobuchopho beschemic esigabeni esibambezelekile ngemuva kokushaywa unhlangothi futhi kubangele isithunywa i-RNA ne-protein expression ye-angiogenic izici. J Vasc Ukuhlinzwa. 2008; 48: 709-714. Buka okungaqondakali.
  93. Yu, H. P., Hsu, J. C., Hwang, T. L., Yen, C. H., noLau, Y.T.Resveratrol inciphisa ukulimala kwe-hepatic ngemuva kokuhlukumezeka-ukopha ngendlela ehlobene ne-estrogen. Ukushaqeka 2008; 30: 324-328. Buka okungaqondakali.
  94. Bass, T. M., Weinkove, D., Houthoofd, K., Gems, D., kanye ne-Partridge, L. Imiphumela ye-resveratrol esikhathini sokuphila ku-Drosophila melanogaster nase-Caenorhabditis elegans. IMech. Ukuguga kwe-Dev 2007; 128: 546-552. Buka okungaqondakali.
  95. UGruber, J., Tang, S. Y., noHalliwell, B.Ubufakazi bokuhweba phakathi kokusinda nokuqina komzimba okubangelwa ukwelashwa nge-resveratrol kwama-elegans eCaenorhabditis. U-Ann N Y. Acad Sci 2007; 1100: 530-542. Buka okungaqondakali.
  96. UBaur, J. A. noSinclair, D. A. Ukwelashwa okungenzeka kwe-resveratrol: ubufakazi obuse-vivo. Nat Rev Izidakamizwa. 2006; 5: 493-506. Buka okungaqondakali.
  97. UValenzano, D. R., Terzibasi, E., Genade, T., Cattaneo, A., Domenici, L., noCellerino, A. Resveratrol yandisa isikhathi sokuphila futhi ibambezela ukuqala kokumaka okuhlobene nobudala ku-vertebrate yesikhashana. ICurr Biol 2-7-2006; 16: 296-300. Buka okungaqondakali.
  98. URakici, O., Kiziltepe, U., Coskun, B., Aslamaci, S., no-Akar, F. Imiphumela ye-resveratrol kwithoni ye-vascular nokusebenza kwe-endothelial kwe-vein saphenous vein kanye ne-artery mammary yangaphakathi. Int. J Cardiol 11-2-2005; 105: 209-215. Buka okungaqondakali.
  99. Ma, Z. H. noMa, Q. Y. Resveratrol: umuthi wezokwelapha we-pancreatitis ebukhali. Umhlaba J Gastroenterol. 6-7-2005; 11: 3171-3174. Buka okungaqondakali.
  100. UMolnar, V. noGarai, J. Izakhi zokulwa nokuvuvukala ezitholwe yizitshalo zithinta umsebenzi we-MIF tautomerase. Int.Immunopharmacol. 2005; 5: 849-856. Buka okungaqondakali.
  101. I-Provinciali, M., Re, F., Donnini, A., Orlando, F., Bartozzi, B., Di Stasio, G., kanye neSmorlesi, A. Umphumela we-resveratrol ekwakhiweni kwezicubu ezizenzekelayo ze-mammary ku-HER-2 / amagundane e-transgenic. Int. J Umdlavuza 5-20-2005; 115: 36-45. Buka okungaqondakali.
  102. U-Aggarwal, B. B., Bhardwaj, A., Aggarwal, R. S., Seeram, N. P., Shishodia, S., noTakada, Y. Indima ye-resveratrol ekuvikeleni nasekwelapheni umdlavuza: izifundo zangaphambi kokuhlinzwa kanye nokwelashwa. I-Anticancer Res. 2004; 24 (5A): 2783-2840. Buka okungaqondakali.
  103. Walle, T., Hsieh, F., DeLegge, M.H, Oatis, J. E., Jr., noWalle, U. K. Ukumuncwa okuphezulu kepha ukutholakala okuphansi kakhulu kwe-resveratrol yomlomo ebantwini. Izidakamizwa zeMetab Yezidakamizwa. 2004; 32: 1377-1382. Buka okungaqondakali.
  104. UJannin, B., Menzel, M., Berlot, J. P., Delmas, D., Lancon, A., noLatruffe, N. Ukuthuthwa kwe-resveratrol, i-agent ye-chemopreventive yomdlavuza, ekuhlosweni kwamaselula: i-plasmatic protein binding and cell uptake. I-Biochem.I-Pharmacol. 9-15-2004; 68: 1113-1118. Buka okungaqondakali.
  105. U-Evers, D. L., Wang, X., Huong, S. M., Huang, D. Y., noHuang, E. S. 3,4 ', 5-Trihydroxy-trans-stilbene (resveratrol) kuvimbela ukuphindaphindeka kwe-cytomegalovirus yabantu nokusayinwa kwamangqamuzana okubangelwa amagciwane. Amagciwane Res. 2004; 63: 85-95. Buka okungaqondakali.
  106. UPiver, B., Fer, M., Vitrac, X., Merillon, JM, Dreano, Y., Berthou, F., noLucas, D. Ukubandakanywa kwe-cytochrome P450 1A2 ku-biotransformation ye-trans-resveratrol kuma-microsomes wesibindi somuntu. . I-Biochem.I-Pharmacol. 8-15-2004; 68: 773-782. Buka okungaqondakali.
  107. UWood, J. G., Rogina, B., Lavu, S., Howitz, K., Helfand, S. L., Tatar, M., noSinclair, D. Izishoshovu zeSirtuin zilingisa ukuvinjelwa kwekhalori futhi zibambezele ukuguga kuma-metazoans. Imvelo 8-5-2004; 430: 686-689. Buka okungaqondakali.
  108. U-Olas, B., Wachowicz, B., Bald, E., noGlowacki, R. Imiphumela yokuvikela i-resveratrol ekushintsheni kwama-platelet thiols abangelwa yi-platinum compounds. UJ. Physiol Pharmacol. 2004; 55: 467-476. Buka okungaqondakali.
  109. UCavallaro, A., Ainis, T., Bottari, C., noFimiani, V. Umphumela we-resveratrol kweminye imisebenzi yama-neutrophil egazi aphelele. IPhysiol Res. 2003; 52: 555-562. Buka okungaqondakali.
  110. UKim, YA, Lee, WH, Choi, TH, Rhee, SH, Park, KY, noChoi, YH Ukubandakanywa kwe-p21WAF1 / CIP1, i-pRB, i-Bax ne-NF-kappaB ekufakweni kokuboshwa kokukhula kanye ne-apoptosis nge-resveratrol ku-human lung carcinoma Amaseli we-A549. Int.J.Oncol. 2003; 23: 1143-1149. Buka okungaqondakali.
  111. Howitz, KT, Bitterman, KJ, Cohen, HY, Lamming, DW, Lavu, S., Wood, JG, Zipkin, RE, Chung, P., Kisielewski, A., Zhang, LL, Scherer, B., noSinclair , Ama-activator we-DA amancane ama-molecule ama-sirtuins anweba impilo ye-Saccharomyces cerevisiae. Imvelo 9-11-2003; 425: 191-196. Buka okungaqondakali.
  112. UDelmas, D., uRebe, C., uLacour, S., uFilomenko, uR., UAthias, A., uGambert, uP., UCherkaoui-Malki, uM, uJannin, uB, uDubrez-Daloz, uL., Latruffe. , N., noSolary, E. I-apoptosis eyenziwe nge-Resveratrol ihlotshaniswa nokwabiwa kabusha kwe-Fas kuma-rafts nokwakhiwa kwesakhiwo esibonisa ukufa esibonisa amangqamuzana omdlavuza wamakholoni. I-J.Biol.Chem. 10-17-2003; 278: 41482-41490. Buka okungaqondakali.
  113. U-Liang, Y. C., Tsai, S. H., Chen, L., Lin-Shiau, S. Y., noLin, J. K. Resveratrol-owenza ukuboshwa kwe-G2 ngokuvimbela i-CDK7 ne-p34CDC2 kinases kumaseli we-colon carcinoma HT29. I-Biochem.I-Pharmacol. 4-1-2003; 65: 1053-1060. Buka okungaqondakali.
  114. UKlinge, C. M., Risinger, K. E., Watts, M. B., Beck, V., Eder, R., noJungbauer, A. Umsebenzi we-Estrogenic emikhakheni yewayini emhlophe nebomvu. J Agric. Ukudla Chem 3-26-2003; 51: 1850-1857. Buka okungaqondakali.
  115. UVitrac, X., Desmouliere, A., Brouillaud, B., Krisa, S., Deffieux, G., Barthe, N., Rosenbaum, J., noMerillon, JM Distribution of [14C] -trans-resveratrol, a i-cancer chemopreventive polyphenol, ezicutshini zegundane ngemuva kokuphathwa ngomlomo. Impilo Sci 4-4-2003; 72: 2219-2233. Buka okungaqondakali.
  116. I-Levenson, AS, Gehm, BD, Pearce, ST, Horiguchi, J., Simons, LA, Ward, JE, III, Jameson, JL, neJordani, i-VC Resveratrol isebenza njenge-agonist ye-estrogen receptor (ER) kumaseli womdlavuza webele ngokuqinile. idluliselwe nge-ER alpha. Int. J. Cancer 5-1-2003; 104: 587-596. Buka okungaqondakali.
  117. U-Yu, C., uShin, u-Y. Ngokushesha Commun.Mass Spectrom. 2003; 17: 307-313. Buka okungaqondakali.
  118. U-Olas, B., Wachowicz, B., Saluk-Juszczak, J., noZielinski, T. Umphumela we-resveratrol, inhlanganisela yemvelo ye-polyphenolic, ekusebenzeni kweplatelet okubangelwa yi-endotoxin noma i-thrombin. ITromb. Res 8-15-2002; 107 (3-4): 141-145. Buka okungaqondakali.
  119. Wallerath, T., Deckert, G., Ternes, T., Anderson, H., Li, H., Witte, K., noForstermann, U. Resveratrol, i-polyphenolic phytoalexin ekhona ewayinini elibomvu, ithuthukisa ukubonakaliswa nokusebenza i-endothelial nitric oxide synthase. Ukusakazwa 9-24-2002; 106: 1652-1658. Buka okungaqondakali.
  120. USharma, M. noGupta, Y. K. Ukwelashwa okungamahlalakhona nge-trans resveratrol kuvimbela i-intracerebroventricular streptozotocin eyenze ukukhubazeka kwengqondo kanye nokucindezeleka kwe-oxidative kumagundane. Impilo Sci 10-11-2002; 71: 2489-2498. Buka okungaqondakali.
  121. UHolian, O., Wahid, S., Atten, M. J., no-Attar, B. M. Ukuvimbela ukwanda kwesifo somdlavuza esiswini nge-resveratrol: indima ye-nitric oxide. Am. J. Physiol Gastrointest; Isilo Physiol 2002; 282: G809-G816. Buka okungaqondakali.
  122. Potter, GA, Patterson, LH, Wanogho, E., Perry, PJ, Butler, PC, Ijaz, T., Ruparelia, KC, iWundlu, i-JH, i-Farmer, i-PB, iStanley, i-LA, ne-Burke, MD I-ejenti yokuvimbela umdlavuza i-resveratrol iguqulelwa ku-agent ye-anticancer piceatannol yi-cytochrome P450 enzyme CYP1B1. UBr. J. Cancer 3-4-2002; 86: 774-778. Buka okungaqondakali.
  123. UFalchetti, R., Fuggetta, M. P., Lanzilli, G., Tricarico, M., noRavagnan, G. Imiphumela ye-resveratrol ekusebenzeni kwamaseli omzimba womuntu. Impilo Sci. 11-21-2001; 70: 81-96. Buka okungaqondakali.
  124. I-Bhavnani, i-BR, i-Cecutti, i-A, i-Gerulath, i-A, i-Woolever, i-AC, ne-Berco, i-M. Ukuqhathanisa imiphumela ye-antioxidant yama-equine estrogens, izingxenye zewayini elibomvu, i-vitamin E, ne-probucol ku-low-density lipoprotein oxidation kwabesifazane be-postmenopausal . Ukunqamuka kokuya esikhathini. 2001; 8: 408-419. Buka okungaqondakali.
  125. Bhat, K. P., Lantvit, D., Christov, K., Mehta, R. G., Moon, R. C., noPezzuto, J. M. Estrogenic kanye ne-antiestrogenic izakhiwo ze-resveratrol kumamodeli we-mammary tumor. Umdlavuza Res. 10-15-2001; 61: 7456-7463. Buka okungaqondakali.
  126. U-Lee, J. E. no-Safe, S. Ukubandakanywa kwendlela yokusebenza ngemuva kokulotshwa ekuvimbeleni inkulumo ye-CYP1A1 nge-resveratrol kumaseli womdlavuza webele. I-Biochem.I-Pharmacol. 10-15-2001; 62: 1113-1124. Buka okungaqondakali.
  127. UBhat, K. P. noPezzuto, J. M. Resveratrol bakhombisa izakhiwo ze-cytostatic kanye ne-antiestrogenic ezinamaseli endometrial adenocarcinoma (Ishikawa). Umdlavuza Res. 8-15-2001; 61: 6137-6144. Buka okungaqondakali.
  128. UNicolini, G., Rigolio, R., Miloso, M., Bertelli, A. A., noTredici, G. Umphumela we-anti-apoptotic we-trans-resveratrol ku-aploptosis eyenziwe nge-paclitaxel emgqeni weseli we-neuroblastoma SH-SY5Y. I-Neurosci. 4-13-2001; 302: 41-44. Buka okungaqondakali.
  129. UGiovannini, L., Migliori, M., Longoni, BM, Das, DK, Bertelli, AA, Panichi, V., Filippi, C., noBertelli, A. Resveratrol, i-polyphenol etholakala ewayinini, inciphisa ukulimala kwe-ischemia reperfusion izinso zamagundane. J Cardiovasc.I-Pharmacol. 2001; 37: 262-270. Buka okungaqondakali.
  130. UChan, W. K. noDelucchi, A. B. Resveratrol, oyinhlangano yewayini elibomvu, i-inactivator esekwe ku-cytochrome P450 3A4. Impilo Sci 11-10-2000; 67: 3103-3112. Buka okungaqondakali.
  131. UWang, M. J., Huang, H. M., Hsieh, S. J., Jeng, K. C., noKuo, J. S. Resveratrol uvimbela ukukhiqizwa kwe-interleukin-6 kumaseli we-gilal axubekile we-cortical ngaphansi kwe-hypoxia / hypoglycemia elandelwa yi-reoxygenation. UJ Neuroimmunol. 1-1-2001; 112 (1-2): 28-34. Buka okungaqondakali.
  132. U-Chang, T. K., Lee, W. B., noKo, H. H. Trans-resveratrol balungisa umsebenzi wokukhuthaza kanye nokubonakaliswa kwe-mRNA kwe-cytochrome yomuntu esebenzisa i-procarcinogen P450 1B1. Ingabe uJ. Physiol Pharmacol. 2000; 78: 874-881. Buka okungaqondakali.
  133. UBurkitt, M. J. noDuncan, J. Imiphumela ye-trans-resveratrol ekwakhekeni kwe-hydroxyl-radical ethembeke ethusi kanye nokulimala kwe-DNA: ubufakazi bokushushumbisa i-hydroxyl-radical kanye neveli, indlela yokwenza okuvikela i-glutathione. I-Arch.I-Biochemys.I-Biophys. 9-15-2000; 381: 253-263. Buka okungaqondakali.
  134. UZbikowska, H. M. no-Olas, B. Ama-antioxidants anomsebenzi we-carcinostatic (i-resveratrol, i-vitamin E ne-selenium) ekushintsheni kokunamathela kweplatelet yegazi. UJ Physiol Pharmacol. 2000; 51: 513-520. Buka okungaqondakali.
  135. Kirk, R. I., Deitch, J. A., Wu, J. M., noLerea, K. M. Resveratrol inciphisa imicimbi yokuqala ukusayinda emaplatelets ageziwe kepha ayinamphumela omncane kuplatethe ekudleni okuphelele. Amaseli Egazi Mol. Dis. 2000; 26: 144-150. Buka okungaqondakali.
  136. Bagchi, D., Bagchi, M., Stohs, S. J., Das, D. K., Ray, S. D., Kuszynski, C. A., Joshi, S. S., kanye no-Pruess, H. G. Ama-radicals amahhala kanye nembewu yamagilebhisi i-proanthocyanidin ekhishwe: ukubaluleka kwezempilo yabantu nokuvikela izifo. I-Toxicology 8-7-2000; 148 (2-3): 187-197. Buka okungaqondakali.
  137. UBradamante, S., Piccinini, F., Barenghi, L., Bertelli, A. A., De Jonge, R., Beemster, P., noDe Jong, J. W. Ngabe i-resveratrol idala ukubekwa phambili kwemithi? Int.J Tissue React. 2000; 22: 1-4. Buka okungaqondakali.
  138. UNaderali, E. K., Doyle, P. J., noWilliams, G. Resveratrol inducate vasorelaxation of mesenteric and uterine arteries from female Guinea Guinea-pigs. I-Clin Sci (Lond) 2000; 98: 537-543. Buka okungaqondakali.
  139. UKlabunde, T., Petrassi, H. M., Oza, V. B., Raman, P., Kelly, J. W., noSacchettini, J. C. Umklamo onengqondo wabantu abanamandla we-transthyretin amyloid disease inhibitors. Nat Struct.Ibhizinisi. 2000; 7: 312-321. Buka okungaqondakali.
  140. UMartinez, J. noMoreno, J. J. Umphumela we-resveratrol, inhlanganisela yemvelo ye-polyphenolic, ezinhlotsheni ze-oxygen ezisebenzayo kanye nasekukhiqizeni i-prostaglandin. I-Biochem. Pharmacol 4-1-2000; 59: 865-870. Buka okungaqondakali.
  141. I-Subbaramaiah, K., Michaluart, P., Chung, W. J., Tanabe, T., Telang, N., noDannenberg, A. J. Resveratrol inhibits cyclooxygenase-2 transcription in human mammary epithelial cell. UMnu.N.Y.Acad.Sci. 1999; 889: 214-223. Buka okungaqondakali.
  142. UDobrydneva, Y., Williams, R. L., noBlackmore, P. F. trans-Resveratrol kuvimbela ukungena kwe-calcium kuma-platelet abantu akhuthazwe yi-thrombin. UBr. J. Pharmacol. 1999; 128: 149-157. Buka okungaqondakali.
  143. UCiolino, H. P. no-Yeh, G. C. Ukuvinjelwa kwe-aryl hydrocarbon eyenziwe nge-cytochrome P-450 1A1 enzyme function kanye ne-CYP1A1 expression by resveratrol. UMol. Pharmacol. 1999; 56: 760-767. Buka okungaqondakali.
  144. U-Lin, J. K. no-Tsai, S. H. Chemoprevention womdlavuza nesifo senhliziyo nge-resveratrol. I-Proc.Natl.Sci.C Council.Repub. China B 1999; 23: 99-106. Buka okungaqondakali.
  145. UZou, J. G., Huang, Y. Z., Chen, Q., Wei, E.H, Hsieh, T. C., noWu, J. M.Resveratrol ivimbela ukuguqulwa kwe-oxidative eyenziwe ngethusi eyenziwe ngamakhemikhali ne-azo. I-Biochem.Mol.I-Biol.Int. 1999; 47: 1089-1096. Buka okungaqondakali.
  146. URahman, I. Intuthuko yokwelashwa kwe-Antioxidant ku-COPD. Ther.Adv.Respir.Dis. 2008; 2: 351-374. Buka okungaqondakali.
  147. UKimura, Y., Okuda, H., noKubo, M. Imiphumela ye-stilbenes ehlukaniswe nezitshalo zokwelapha ku-arachidonate metabolism kanye ne-degranulation kuma-leukocyte womuntu we-polymorphonuclear. J Ethnopharmacol. 1995; 45: 131-139. Buka okungaqondakali.
  148. UTome-Carneiro, J., Gonzalvez, M., Larrosa, M., Garcia-Almagro, FJ, Aviles-Plaza, F., Parra, S., Yanez-Gascon, MJ, Ruiz-Ros, JA, Garcia-Conesa , MT, Tomas-Barberan, FA, no-Espin, JC Ukusetshenziswa kwesengezo sokukhishwa kwamagilebhisi okuqukethe i-resveratrol kunciphisa i-LDL ene-oxidized ne-ApoB ezigulini ezithola ukuvinjelwa okuyinhloko kwesifo senhliziyo: ukulandelwa okuphindwe kathathu, okuyizinyanga eziyisithupha, ukulawulwa kwe-placebo , ukulingwa okungahleliwe. Mol.Nutr Ukudla Res 2012; 56: 810-821. Buka okungaqondakali.
  149. UTome-Carneiro, J., Gonzalvez, M., Larrosa, M., Yanez-Gascon, MJ, Garcia-Almagro, FJ, Ruiz-Ros, JA, Garcia-Conesa, MT, Tomas-Barberan, FA, no-Espin, I-JC Ukusetshenziswa konyaka owodwa kwe-nutraceutical yamagilebhisi equkethe i-resveratrol kuthuthukisa isimo sokuvuvukala kanye ne-fibrinolytic yeziguli ekuvikeleni okuyinhloko kwesifo senhliziyo. NginguJ Cardiol. 8-1-2012; 110: 356-363. Buka okungaqondakali.
  150. UZern, TL, Wood, RJ, Greene, C., West, KL, Liu, Y., Aggarwal, D., Shachter, NS, noFernandez, ML Amagilebhisi ama-polyphenols enza umphumela wokuvikela inhliziyo kwabesifazane bangaphambi nangemva kokuya esikhathini ngokunciphisa iplasma lipids nokunciphisa ukucindezeleka okwenziwe nge-oxidative. J Umsoco. 2005; 135: 1911-1917. Buka okungaqondakali.
  151. UPiver, B., Berthou, F., Dreano, Y., noLucas, D. Ukwahlukaniswa okwehlukile kwama-enzyme e-cytochrome P450 womuntu yi-epsilon-viniferin, ubukhulu be-resveratrol: ukuqhathanisa ne-resveratrol ne-polyphenols kusuka kuziphuzo ezinotshwala. Impilo Sci. 7-18-2003; 73: 1199-1213. Buka okungaqondakali.
  152. de, Santi C., Pietrabissa, A., Mosca, F., noPacifici, G. M. Glucuronidation of resveratrol, umkhiqizo wemvelo okhona kumagilebhisi newayini, esibindini somuntu. I-Xenobiotica 2000; 30: 1047-1054. Buka okungaqondakali.
  153. URosa, F.T, Zulet, M. A., Marchini, J. S., noMartinez, J. A. Bioactive compounds nemiphumela kumamaki wokuvuvukala kubantu. I-Int J Food Sci Nutriti 2012; 63: 749-765. Buka okungaqondakali.
  154. U-Chang, T. K., Chen, J., no-Lee, W. B. Ukwehluka kokuvimbela nokungasebenzi kwama-enzyme e-CYP1 womuntu nge-trans-resveratrol: ubufakazi bokusetshenziswa kwendlela yokusebenza kwe-CYP1A2. J.Pharmacol.Exp.Ther. 2001; 299: 874-882. Buka okungaqondakali.
  155. Ngokuyinhloko, J. P., Marre-Fournier, F., Le Bail, J. C., Habrioux, G., noChulia, A. J. Estrogenic / antiestrogenic kanye nokuqothula izakhiwo ze (E) - kanye (Z) -resveratrol. Impilo Sci. 1-21-2000; 66: 769-777. Buka okungaqondakali.
  156. UMueller SO, uSimon S, uChae K, et al. Ama-Phytoestrogens nama-metabolite awo angabantu abonisa izakhiwo ezihlukile ze-agonistic neziphikisayo ku-estrogen receptor alpha (ERalpha) ne-ERbeta kumaseli womuntu. I-Toxicol Sci 2004; 80: 14-25. Buka okungaqondakali.
  157. UBoocock DJ, uFaust GE, uPatel KR, et al. Isigaba I isilinganiso sokukhula kwesifundo se-pharmacokinetic kumavolontiya anempilo we-resveratrol, i-ejenti yomdlavuza engaba nomdlavuza. I-Cancer Epidemiol Biomarkers Prev 2007; 16: 1246-52. Buka okungaqondakali.
  158. ILyons MM, Yu C, iToma RB, et al. I-Resveratrol kuma-blueberries aluhlaza futhi abhakabhakeni nama-bilberries. J Agric Ukudla Chem 2003; 51: 5867-70. Buka okungaqondakali.
  159. UTrincheri NF, uNicotra G, uFollo C, et al. I-Resveratrol inciphisa ukufa kwamangqamuzana kumaseli omdlavuza obala ngendlela yoveli ehilela i-lysosomal cathepsin D. Carcinogenesis 2007; 28: 922-31. Buka okungaqondakali.
  160. UScarlatti F, uSala G, uSomenzi G, et al. I-Resveratrol inciphisa ukukhula kokuvimbela kanye ne-apoptosis kumaseli womdlavuza webele we-metastatic nge-de novo ceramide signaling. I-FASEB J 2003; 17: 2339-41. Buka okungaqondakali.
  161. UWang Q, Li H, uWang XW, et al. I-Resveratrol ikhuthaza ukwahlukanisa futhi inciphisa i-Fas-independent apoptosis yamaseli we-medulloblastoma yabantu. UNeurosci Lett 2003; 351: 83-6. Buka okungaqondakali.
  162. UCulpitt SV, uRogers DF, uFenwick PS, et al. Ukuvimbela ukukhishwa kwewayini elibomvu, i-resveratrol, yokukhishwa kwe-cytokine ngama-alveolar macrophages ku-COPD. Isikhulu 2003; 58: 942-6. Buka okungaqondakali.
  163. I-Pervaiz S. Resveratrol: kusuka kumagilebhisi kuya ku-biology yemammalia. I-FASEB J 2003; 17: 1975-85. Buka okungaqondakali.
  164. USavaskan E, u-Olivieri G, uMeier F, et al. Isithako sewayini elibomvu i-resveratrol ivikela i-beta-amyloid neurotoxicity. IGerontology 2003; 49: 380-3. Buka okungaqondakali.
  165. UGao X, uDeeb D, iMedia J, et al. Umsebenzi we-immunomodulatory we-resveratrol: ukungafani kwe-vitro kanye nemiphumela ye-vivo ye-immunological. I-Biochem Pharmacol 2003; 66: 2427-35. Buka okungaqondakali.
  166. ISchriever C, iPendland SL, i-Mahady GB. Iwayini elibomvu, i-resveratrol, iChlamydia pneumoniae kanye nokuxhumana kwaseFrance. I-Atherosclerosis 2003; 171: 379-80. Buka okungaqondakali.
  167. IZiegler CC, Amanzi Emvula L, uWhelan J, McEntee MF. I-resveratrol yokudla ayithinti i-tumorigenesis yamathumbu kumagundane e-Apc (Min / +). UJ Nutriti 2004; 134: 5-10. Buka okungaqondakali.
  168. UKim YA, uChoi BT, uLee YT, et al. I-Resveratrol inqanda ukwanda kweseli futhi inciphisa i-apoptosis yamaseli webele carcinoma MCF-7 amaseli. U-Oncol Rep 2004; 11: 441-6. Buka okungaqondakali.
  169. UZhang Y, Jayaprakasam B, Seeram NP, et al. Ukuvinjelwa kwe-insulin kanye nokuvinjelwa kwe-cyclooxygenase enzyme yi-cabernet sauvignon yamagilebhisi esikhumba somvini. J Agric Ukudla Chem 2004; 52: 228-33. Buka okungaqondakali.
  170. U-Opipari AW Jr, Tan L, Boitano AE, et al. I-Resveratrol-indosed autophagocytosis kumaseli womdlavuza we-ovari. ICancer Res 2004; 64: 696-703. Buka okungaqondakali.
  171. I-Abou-Zeid LA, El-Mowafy AM. Ukwehlukaniswa kokuqashelwa kwama-resveratrol isomers yi-estrogen receptor-alpha yomuntu: ubufakazi bamandla emangqamuzana wokubopha kwe-ligos stereoselective. Ukuziphatha 2004; 16: 190-5. Buka okungaqondakali.
  172. UMeng X, Maliakal P, Lu H, et al. Amazinga e-urinary ne-plasma we-resveratrol ne-quercetin kubantu, kumagundane, nakumagundane ngemuva kokungeniswa kwamakhompiyutha amsulwa nejusi lamagilebhisi. J Agric Ukudla Chem 2004; 52: 935-42. Buka okungaqondakali.
  173. UHascalik S, uCelik O, uTurkoz Y, et al. I-Resveratrol, i-red wine constituent polyphenol, ivikela ekulimaleni kwe-ischemia-reperfusion kwama-ovari. IGynecol Obstet Invest 2004; 57: 218-23. Buka okungaqondakali.
  174. U-Ahmad KA, uClement MV, uHanif IM, uPervaiz S. Resveratrol uvimbela i-apoptosis eyenziwe yizidakamizwa kumaseli we-leukemia womuntu ngokwakha indawo engaphakathi kweseli engavumelekile ukubulawa kwabantu. ICancer Res 2004; 64: 1452-9. Buka okungaqondakali.
  175. Li W, Seifert M, Xu Y, Hock B. Ucwaningo lokuqhathanisa amandla e-estrogenic e-estradiol, tamoxifen, bisphenol-A kanye ne-resveratrol enama-in vitro bioassays amabili. I-Environ Int 2004; 30: 329-35. Buka okungaqondakali.
  176. UMartin AR, uVillegas I, uLa Casa C, de la Lastra CA. I-Resveratrol, i-polyphenol etholakala kumagilebhisi, icindezela ukulimala kwe-oxidative futhi ivuselele i-apoptosis ngesikhathi sokuvuvukala kokuqala kwamakholoni kumagundane. I-Biochem Pharmacol 2004; 67: 1399-410. Buka okungaqondakali.
  177. I-Szewczuk LM, i-Forti L, i-Stivala LA, i-Penning TM.I-Resveratrol iyi-peroxidase Mediated inactivator ye-COX-1 kepha hhayi i-COX-2: Indlela yokwenza ekwakhiweni kwezinhlaka ezikhethiwe ze-COX-1. UJ Biol Chem 2004; 279: 22727-37. Buka okungaqondakali.
  178. UWang Z, uHuang Y, uZou J, et al. Imiphumela yewayini elibomvu newayini i-polyphenol resveratrol ku-platelet aggregation ku-vivo naku-vitro. I-Int J Mol Med 2002; 9: 77-9. Buka okungaqondakali.
  179. UMokni M, uLimam F, u-Elkahoui S, et al. Umphumela oqinile we-cardioprotective we-resveratrol, i-red wine polyphenol, ezinhliziyweni zezintambo ezizimele ngemuva kokulimala kwe-ischemia / reperfusion. I-Arch Biochem Biophys 2007; 457: 1-6. Buka okungaqondakali.
  180. U-Elmali N, uBaysal O, uHarma A, et al. Imiphumela ye-resveratrol ku-arthritis yokuvuvukala. Ukuvuvukala 2007; 30: 1-6. Buka okungaqondakali.
  181. UBujanda L, uGarcia-Barcina M, uGutierrez-de Juan V, et al. Umphumela we-resveratrol ekufeni okubangelwa utshwala kanye nezilonda zesibindi kumagundane. I-BMC Gastroenterol 2006; 6: 35. Buka okungaqondakali.
  182. IBaur JA, Pearson KJ, Intengo NL, et al. I-Resveratrol ithuthukisa impilo nokusinda kwamagundane ekudleni okuphezulu kwekhalori. Imvelo 2006; 444: 337-42. Buka okungaqondakali.
  183. UMurias M, uHandler N, u-Erker T, et al. Ama-analogs we-Resveratrol njengama-inhibitor akhethiwe e-cyclooxygenase-2: ubuhlobo bokuqala nokwenziwa komsebenzi. I-Bioorg Med Chem 2004; 12: 5571-8. Buka okungaqondakali.
  184. UHwang D, Fischer NH, Jang BC, et al. Ukuvinjelwa kokuvezwa kwe-cyclooxygenase ne-cytokines e-proinfigueatory ngama-sesquiterpene lactones kuma-macrophages ahambisana nokuvinjelwa kwe-MAP kinases. I-Biochem Biophys Res Commun 1996; 226: 810-8 .. Buka okungaqondakali.
  185. Takada Y, Bhardwaj A, Potdar P, Aggarwal BB. Ama-nonsteroidal anti-inflammatory agents ahlukile ngokwazi kwawo ukucindezela ukwenziwa kwe-NF-kappaB, inhibition of expression of cyclooxygenase-2 and cyclin D1, and abrogation of tumor cell proliferation. U-Oncogene 2004; 23: 9247-58. Buka okungaqondakali.
  186. IGoldberg DM, uYan J, uSoleas GJ. Ukumuncwa kwama-polyphenols amathathu ahlobene newayini kumatikuletsheni amathathu ahlukene ngezifundo ezinempilo. I-Clin Biochem 2003; 36: 79-87 .. Buka okungaqondakali.
  187. UDocherty JJ, uFu MM, uStiffler BS, et al. Resveratrol inhibition of herpes simplex virus replication. I-Antiviral Res 1999; 43: 145-55. Buka okungaqondakali.
  188. IBowers JL, iTyulmenkov VV, iJernigan SC, iKlinge CM. I-Resveratrol isebenza njenge-agonist / antagonist exubile ye-estrogen receptors alpha ne-beta. I-Endocrinology 2000; 141: 3657-67.
  189. UPiver B, uBerthou F, uDreano Y, uLucas D. Ukuvinjelwa kwemisebenzi ye-CYP3A, CYP1A ne-CYP2E1 nge-resveratrol nangezinye izingxenye zewayini elibomvu ezingashintshi. I-Toxicol Lett 2001; 125: 83-91. Buka okungaqondakali.
  190. ILaden BP, iPorter TD. I-Resveratrol ivimbela i-squalene monooxygenase yabantu. I-Nut Res 2001; 21: 747-53.
  191. UKozuki Y, Miura Y, Yagasaki K.Resveratrol icindezela ukuhlasela kweseli le-hepatoma ngaphandle kwesenzo sayo sokulwa nokwanda. Umdlavuza Lett 2001; 167: 151-6. Buka okungaqondakali.
  192. USchneider Y, Vincent F, uDuranton B, et al. Umphumela wokulwa nokwanda kwe-resveratrol, ingxenye yemvelo yamagilebhisi newayini, kumaseli womdlavuza womuntu. ICancer Lett 2000; 158: 85-91.
  193. UJacobson JS, uTroxel AB, u-Evans J, et al. Ukuhlolwa okungahleliwe kwe-cohosh emnyama yokwelashwa kokushisa okushisayo phakathi kwabesifazane abanomlando womdlavuza webele. UJ Clin Oncol 2001; 19: 2739-45. Buka okungaqondakali.
  194. IHolmes-McNary M, Baldwin AS, Jr.Izakhiwo zeChemopreventive ze-trans-resveratrol zihlotshaniswa nokuvimbela ukusebenza kwe-IkappaB kinase. ICancer Res 2000; 60: 3477-83. Buka okungaqondakali.
  195. UBertelli AA, uGiovannini L, uGiannessi D, et al. Umsebenzi we-antiplatelet we-resveratrol yokwenziwa nemvelo ewayinini elibomvu. I-Int J Tissue React 1995; 17: 1-3. Buka okungaqondakali.
  196. UGehm BD, uMcAndrews JM, uChien PY, uJameson JL. I-Resveratrol, inhlanganisela ye-polyphenolic etholakala kumagilebhisi newayini, i-agonist ye-estrogen receptor. I-Proc Natl Acad Sci U S A 1997; 94: 14138-43. Buka okungaqondakali.
  197. UCarbo N, uCostelli P, uBaccino FM, et al. I-Resveratrol, umkhiqizo wemvelo okhona ewayinini, inciphisa ukukhula kwesimila kumodeli we-rat tumor. I-Biochem Biophys Res Commun 1999; 254: 739-43. Buka okungaqondakali.
  198. I-Huang C, i-Ma WY, i-Goranson A, i-Dong Z. I-Resveratrol icindezela ukuguqulwa kwamaseli futhi inciphisa i-apoptosis ngendlela encike ku-p53. ICarcinogenesis 1999; 20: 237-42. Buka okungaqondakali.
  199. UDavy BM, uMelby CL, uBeske SD, et al. Ukusetshenziswa kwe-oat akuphazamisi ukuphumula kwengcindezi yegazi e-24-h yegazi emadodeni ane-high blood pressure ejwayelekile ukuze afike I-hypertension. J Nutrit 2002; 132: 394-8 .. Buka okungaqondakali.
  200. I-Chen CK, i-Pace-Asciak CR. Umsebenzi we-Vasorelaxing we-resveratrol ne-quercetin ku-rat aorta ehlukile. UGen Pharmacol 1996; 27: 363-6. Buka okungaqondakali.
  201. I-Bertelli A, i-Bertelli AA, i-Gozzini A, i-Giovannini L. I-Plasma kanye nokugxila kwezicubu ze-resveratrol nomsebenzi wezemithi. Izidakamizwa Exp Clin Res 1998; 24: 133-8. Buka okungaqondakali.
  202. UPace-Asciak CR, uHahn S, uDiamandis EP, et al. I-red wine phenolics trans-resveratrol ne-quercetin ivimba ukuhlanganiswa kweplatelet yabantu kanye ne-eicosanoid synthesis: imiphumela yokuvikelwa kwisifo senhliziyo. Umtholampilo Chim Acta 1995; 235: 207-19. Buka okungaqondakali.
  203. UBertelli AA, uGiovannini L, uBernini W, et al. Umsebenzi we-antiplatelet we-cis-resveratrol. Izidakamizwa Exp Clin Res 1996; 22: 61-3. Buka okungaqondakali.
  204. I-Pace-Asciak CR, iRounova O, iHahn SE, et al. Amawayini namajusi wamagilebhisi njengama-modulators we-platelet aggregation ezifundweni zabantu ezinempilo. Umtholampilo Chim Acta 1996; 246: 163-82. Buka okungaqondakali.
  205. UJang M, Cai L, Udeani GO, et al. Umsebenzi womdlavuza wokuvikela umdlavuza we-resveratrol, umkhiqizo wemvelo othathwe kumagilebhisi. Isayensi 1997; 275: 218-20. Buka okungaqondakali.
  206. Soleas GJ, Diamandis EP, Goldberg DM. I-Resveratrol: i-molecule isikhathi sayo sesifikile? Futhi uhambe? I-Clin Biochem 1997; 30: 91-113. Buka okungaqondakali.
  207. I-Agri Res Svc: Imininingwane yolwazi kaDkt Duke ne-ethnobotanical. www.ars-grin.gov/duke (Kufinyelelwe ngomhla ka-3 Novemba 1999).
  208. Ukubuyekezwa Kwemikhiqizo Yemvelo ngamaqiniso nokuqhathanisa. ISt. Louis, MO: IWolters Kluwer Co., 1999.
  209. UFoster S, uTyler VE. Amakhambi Athembekile KaTyler: Umhlahlandlela Oqondakalayo Wokusetshenziswa Kwamakhambi Namakhambi Ahlobene. 3rd ed., Binghamton, NY: I-Haworth Herbal Press, ngo-1993.
  210. INewall CA, Anderson LA, uPhilpson JD. Herbal Medicine: Umhlahlandlela Wongoti Bezempilo. ILondon, e-UK: I-Pharmaceutical Press, ngo-1996.
  211. UTyler VE. Amakhambi Okuzikhethela. IBinghamton, NY: Imikhiqizo Yemikhiqizo Yezokwelapha, 1994.
  212. UBlumenthal M, u-ed. I-Complete German Commission E Monographs: Umhlahlandlela Wezokwelapha Emithini Yemithi. I-Trans. S. Klein. IBoston, MA: Umkhandlu Wezamabhodlela waseMelika, ngo-1998.
  213. Ama-monographs ngokusetshenziswa kokwelashwa kwemithi yezitshalo. I-Exeter, e-UK: I-European Scientific Co-op Phytother, ngo-1997.
Kugcine ukubuyekezwa - 09/30/2020

Imibhalo Ye-Portal

I-Bronchopneumonia: Izimpawu, Izingozi, kanye Nokwelapha
Impilo

I-Bronchopneumonia: Izimpawu, Izingozi, kanye Nokwelapha

Iyini i-bronchopneumonia?I-pneumonia i igaba okutheleleka kwamaphaphu. Kwenzeka lapho amagciwane, amabhaktheriya, noma i ikhunta kubangela ukuvuvukala nokutheleleka kuma-alveoli (ama aka amancane omo...
Ungaliphuza Ikhofi Lapho Ugula?
Umsoco

Ungaliphuza Ikhofi Lapho Ugula?

Uma ugula, kungokwemvelo ukufuna ukudla neziphuzo eziduduzayo okujwayele. Kubantu abaningi, lokho kufaka ikhofi.Kubantu abaphilile, ikhofi linemiphumela embalwa emibi lapho lidliwa ngokulingani ela. K...